-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Zilovertamab Vedotin in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Zilovertamab Vedotin in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Zilovertamab Vedotin in Triple-Negative Breast Cancer (TNBC) Drug...
-
Sector Analysis
Ovarian Cancer Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032
Ovarian Cancer Market Report Overview The ovarian cancer market across the 7MM was valued at $3.3 billion in 2022. The market will grow at a CAGR of more than 1% from 2022 to 2032. Ovarian cancer is one of the most lethal gynecological cancers worldwide. Each year in the US, more than 19,700 women receive a new diagnosis of ovarian cancer. Â The following are some of the key highlights of the ovarian cancer market: Report deliverables include a PowerPoint report...
-
Sector Analysis
Spinal Non-Fusion Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Spinal Non-Fusion Market Report Overview The spinal non-fusion market size was $884.8 million in 2023. The market is expected to grow at a CAGR of more than 5% during 2023-2033. Spinal non-fusion surgery is performed to treat spinal instability, degenerative disc disorder, and spinal stenosis while preserving the spine's normal motion, load bearing, and shock absorption capacity. Spinal non-fusion surgery also provides pain relief without major anatomical removal. Spinal Non-Fusion Market Outlook, 2023-2033 ($ Million) Buy the Full Report for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pentosan Polysulfate Sodium in Alphavirus Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pentosan Polysulfate Sodium in Alphavirus Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pentosan Polysulfate Sodium in Alphavirus Infections Drug Details: Pentosan polysulfate...
-
Product Insights
Image Guided Surgery Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Image Guided Surgery Pipeline Market Report Overview Image Guided Surgery devices use real-time images during surgery to assist surgeons in precisely guiding the surgical instruments to the anatomic structures. It helps minimize the chances of errors and reduce the procedure time. The Image Guided Surgery pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are...
-
Product Insights
NewEdema – Drugs In Development, 2024
Empower your strategies with our Edema – Drugs In Development, 2024 report and make more profitable business decisions. Edema is a condition where excess fluid accumulation is observed in the limbs bilaterally, appearing as as puffiness or swelling. This condition can be temporary, depending on the cause of the condition. There are various etiological factors: long-standing, low protein levels, pregnancy, chronic kidney disease (CKD), congestive heart failure (CHF), liver cirrhosis, venous insufficiency, and lung conditions like emphysema. Physical examination is the...
-
Product Insights
NewSeasonal Allergic Rhinitis – Drugs In Development, 2024
Empower your strategies with our Seasonal Allergic Rhinitis – Drugs In Development, 2024 report and make more profitable business decisions. Seasonal allergic rhinitis (SAR), commonly referred to as hay fever, is an inflammatory condition affecting the upper airways in response to exposure to airborne allergens, typically pollen from trees, grasses, and weeds, particularly prevalent in certain seasons. This condition manifests in sensitized individuals, giving rise to symptoms such as sneezing, nasal congestion, a runny nose, itchy or watery eyes, and fatigue....
-
Product Insights
NewEpidermolysis Bullosa – Drugs In Development, 2024
Empower your strategies with our Epidermolysis Bullosa – Drugs In Development, 2024 report and make more profitable business decisions. Epidermolysis bullosa (EB) is a group of inherited bullous disorders characterized by blister formation in response to mechanical trauma. Symptoms include blistering of skin; deformity or loss of fingernails and toenails; internal blistering including on the throat, esophagus, upper airway, stomach, intestines, and urinary tract; skin thickening on palms and soles of the feet (hyperkeratosis); and scalp blistering, scarring, and hair loss...